{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:01:22Z","timestamp":1782007282603,"version":"3.54.5"},"reference-count":144,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaip.2026.01.027","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:37:31Z","timestamp":1772606251000},"page":"542-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Differential Diagnosis of Eosinophilic Lung Diseases"],"prefix":"10.1016","volume":"14","author":[{"given":"Giacomo","family":"Emmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Baratella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Akuthota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe G.","family":"Loscocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.01.027_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.iac.2023.01.002","article-title":"Eosinophilic lung diseases","volume":"43","author":"Cottin","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2026.01.027_bib2","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaci.2007.03.048","article-title":"Eosinophil trafficking in allergy and asthma","volume":"119","author":"Rosenberg","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.027_bib3","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/all.12088","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): state of the art","volume":"68","author":"Vaglio","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.027_bib5","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.027_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1164\/rccm.202005-1628SO","article-title":"International Consensus on Antineutrophil Cytoplasm Antibodies Testing in Eosinophilic Granulomatosis with Polyangiitis","volume":"202","author":"Moiseev","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sabl\u00e9-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaip.2026.01.027_bib9","first-page":"299","article-title":"Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases","volume":"77","author":"Marchand","year":"1998","journal-title":"The Groupe d\u2019Etudes et de Recherche sur les Maladies \u201cOrphelines\u201d Pulmonaires (GERM\"O\"P). Medicine"},{"key":"10.1016\/j.jaip.2026.01.027_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.iac.2023.01.005","article-title":"Connective tissue disease associated interstitial lung disease","volume":"43","author":"Matson","year":"2023","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2026.01.027_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/imj.70026","article-title":"Connective tissue disease-associated interstitial lung disease: an approach to treatment amidst an expanding evidence base","volume":"55","author":"Hong","year":"2025","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaip.2026.01.027_bib12","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1164\/ajrccm.150.5.7952571","article-title":"Eosinophilic lung diseases","volume":"150","author":"Allen","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41584-023-00958-w","article-title":"Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis","volume":"19","author":"Emmi","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib14","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.mayocp.2023.02.013","article-title":"HES and EGPA: two sides of the same coin","volume":"98","author":"Khoury","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2026.01.027_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/all.15544","article-title":"Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes","volume":"78","author":"Valent","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.01.027_bib16","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jaip.2022.03.034","article-title":"Clinical profile and treatment in hypereosinophilic syndrome variants: a pragmatic review","volume":"10","author":"Requena","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.027_bib17","doi-asserted-by":"crossref","first-page":"i92","DOI":"10.1093\/rheumatology\/keae608","article-title":"Highlights from the plenary session: eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome","volume":"64","author":"Holle","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaip.2026.01.027_bib18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jaci.2020.08.037","article-title":"Efficacy and safety of mepolizumab in hypereosinophilic syndrome: a phase III, randomized, placebo-controlled trial","volume":"146","author":"Roufosse","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.027_bib19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jaip.2025.03.016","article-title":"Long-term efficacy and safety of benralizumab treatment for PDGFRA-negative hypereosinophilic syndrome","volume":"13","author":"Kuang","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.027_bib20","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.103011","article-title":"Parasitic-induced Loeffler\u2019s syndrome: a systematic review based on clinical reports","volume":"19","author":"Faridah","year":"2026","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.jaip.2026.01.027_bib22","first-page":"295","article-title":"Tropical pulmonary eosinophilia\u2014a review","volume":"138","author":"Mullerpattan","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jaip.2026.01.027_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/MCP.0b013e3281eb8ec9","article-title":"Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management","volume":"13","author":"Vijayan","year":"2007","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s40475-020-00221-2","article-title":"Soil-transmitted helminths in the USA: a review of five common parasites and future directions for avenues of enhanced epidemiologic inquiry","volume":"8","author":"Lynn","year":"2021","journal-title":"Curr Trop Med Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib25","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-023-00490-x","article-title":"Strongyloidiasis","volume":"10","author":"Gordon","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2026.01.027_bib26","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/00007611-199907000-00016","article-title":"Bacterial complications of strongyloidiasis: Streptococcus bovis meningitis","volume":"92","author":"Link","year":"1999","journal-title":"South Med J"},{"key":"10.1016\/j.jaip.2026.01.027_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/QCO.0000000000000915","article-title":"Strongyloidiasis-related lung involvement: too much of a bad thing","volume":"36","author":"Barkati","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1128\/CVI.00041-14","article-title":"Comparison of three immunoassays for detection of antibodies to Strongyloides stercoralis","volume":"21","author":"Anderson","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jaip.2026.01.027_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.mcg.0000152779.68900.33","article-title":"Intestinal strongyloidiasis: recognition, management, and determinants of outcome","volume":"39","author":"Concha","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaip.2026.01.027_bib30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1086\/630201","article-title":"Strongyloidiasis in transplant patients","volume":"49","author":"Roxby","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib31","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/infdis\/169.5.1076","article-title":"A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis","volume":"169","author":"Gann","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib32","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00408-022-00528-z","article-title":"Strongyloides stercoralis","volume":"200","author":"Czeresnia","year":"2022","journal-title":"Lung"},{"key":"10.1016\/j.jaip.2026.01.027_bib33","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1164\/ajrccm\/145.4_Pt_1.961","article-title":"Pulmonary involvement in loiasis","volume":"145","author":"Klion","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/lungindia.lungindia_696_20","article-title":"Lophomonas isolation in sputum sample at Peru","volume":"38","author":"Moya-Salazar","year":"2021","journal-title":"Lung India"},{"key":"10.1016\/j.jaip.2026.01.027_bib35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MAJ.0000000000000578","article-title":"Clinical features of pulmonary sparganosis","volume":"350","author":"Li","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jaip.2026.01.027_bib36","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.idc.2024.11.012","article-title":"Coccidioidomycosis","volume":"39","author":"Donovan","year":"2025","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.jaip.2026.01.027_bib37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1148\/rg.344130134","article-title":"Pulmonary coccidioidomycosis: pictorial review of chest radiographic and CT findings","volume":"34","author":"Jude","year":"2014","journal-title":"Radiographics"},{"key":"10.1016\/j.jaip.2026.01.027_bib38","doi-asserted-by":"crossref","first-page":"i40","DOI":"10.1093\/jac\/dkaf002","article-title":"Coccidioidomycosis: a growing global concern","volume":"80","author":"Donovan","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jaip.2026.01.027_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.prrv.2009.08.001","article-title":"Paracoccidioidomycosis","volume":"10","author":"Ferreira","year":"2009","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.jaip.2026.01.027_bib40","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3389\/fimmu.2018.02346","article-title":"Allergic bronchopulmonary aspergillosis\u2014a luminal hypereosinophilic disease with extracellular trap cell death","volume":"9","author":"Ueki","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.01.027_bib41","first-page":"220","article-title":"A young immunocompetent patient with spontaneous Aspergillus empyema who developed severe eosinophilia","volume":"22","author":"Kudo","year":"2017","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib42","article-title":"Invasive pulmonary aspergillosis with marked eosinophilia as a unique presentation of chronic granulomatous disease","volume":"9","author":"Van Woensel","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-213205","article-title":"Invasive aspergillosis presenting as an intracardiac mass in an immunocompetent host","volume":"2016","author":"Bajaj","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1752-1947-6-270","article-title":"Systemic dissemination of chronic necrotizing pulmonary aspergillosis in an elderly woman without comorbidity: a case report","volume":"6","author":"Tokui","year":"2012","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib45","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.2008-740ST","article-title":"An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients","volume":"183","author":"Limper","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib46","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/15513815.2016.1153175","article-title":"Eosinophilia in preterm born infants infected with Chlamydia trachomatis","volume":"35","author":"L\u00f3pez-Hurtado","year":"2016","journal-title":"Fetal Pediatr Pathol"},{"key":"10.1016\/j.jaip.2026.01.027_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.08.1567","article-title":"Mycobacterium avium complex-induced chronic eosinophilic pneumonia: a case report","volume":"156","author":"Arshed","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.027_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12931-017-0579-9","article-title":"An association between pulmonary Mycobacterium avium-intracellulare complex infections and biomarkers of Th2-type inflammation","volume":"18","author":"Pfeffer","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.01.027_bib49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20210469","article-title":"Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice","volume":"218","author":"Bohrer","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.8085","article-title":"Tuberculosis manifesting with significant peripheral eosinophilia: a case report and review of literature","volume":"11","author":"Damera","year":"2023","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1378\/chest.102.1.54","article-title":"Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis","volume":"102","author":"Ozaki","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.027_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s13054-020-03361-z","article-title":"Eosinophilia in critically ill COVID-19 patients: a French monocenter retrospective study","volume":"24","author":"Fraiss\u00e9","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/j.jaip.2026.01.027_bib53","article-title":"A case of acute eosinophilic pneumonia triggered by the SARS-CoV-2 virus","volume":"15","author":"Monteiro","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2026.01.027_bib54","article-title":"Acute eosinophilic pneumonia associated with COVID-19 infection","volume":"14","author":"Vogel","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.jaip.2026.01.027_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MCP.0000000000000761","article-title":"Pulmonary pathology of COVID-19: a review of autopsy studies","volume":"27","author":"Borczuk","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2021.12.002","article-title":"Allergic bronchopulmonary aspergillosis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib57","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.coi.2020.10.005","article-title":"Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases","volume":"66","author":"Barry","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaip.2026.01.027_bib58","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.08-2586","article-title":"Allergic bronchopulmonary aspergillosis","volume":"135","author":"Agarwal","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.027_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0043-1777259","article-title":"Aspergillus and the lung","volume":"45","author":"Janssens","year":"2024","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib60","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.027_bib61","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.01.027_bib62","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJM200003163421102","article-title":"A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis","volume":"342","author":"Stevens","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib63","article-title":"Dupilumab improves lung function, asthma control and exacerbation frequency in allergic bronchopulmonary aspergillosis\u2014results from the phase 2 LIBERTY ABPA","volume":"211","author":"Bourdin","year":"2025","journal-title":"AIRED study"},{"key":"10.1016\/j.jaip.2026.01.027_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2214\/ajr.128.1.1","article-title":"Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema","volume":"128","author":"Gaensler","year":"1977","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2026.01.027_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-1-11","article-title":"Idiopathic chronic eosinophilic pneumonia","volume":"1","author":"Marchand","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib66","series-title":"History of Allergy","author":"Bergmann","year":"2014"},{"key":"10.1016\/j.jaip.2026.01.027_bib67","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archinte.1922.00110120002001","article-title":"The pathology of bronchial asthma","volume":"30","author":"Huber","year":"1922","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib68","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1126\/science.1100283","article-title":"A critical role for eosinophils in allergic airways remodeling","volume":"305","author":"Humbles","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.01.027_bib69","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1126\/science.1099472","article-title":"Defining a link with asthma in mice congenitally deficient in eosinophils","volume":"305","author":"Lee","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jaip.2026.01.027_bib70","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.027_bib71","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.027_bib72","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.027_bib73","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S2213-2600(15)00042-9","article-title":"Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"3","author":"Castro","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib74","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(58)91385-0","article-title":"Treatment of chronic asthma with prednisolone: significance of eosinophils in the sputum","volume":"2","author":"Morrow Brown","year":"1958","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.01.027_bib75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","article-title":"Eosinophilic and noneosinophilic asthma","volume":"197","author":"Carr","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib76","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib77","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib78","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib79","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaip.2019.11.024","article-title":"Eosinophilic asthma","volume":"8","author":"Nelson","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.027_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib81","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.027_bib82","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJMoa2413181","article-title":"Mepolizumab to prevent exacerbations of COPD with an eosinophilic phenotype","volume":"392","author":"Sciurba","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-022-03402-8","article-title":"Updates on eosinophilic disorders","volume":"482","author":"Tzankov","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jaip.2026.01.027_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1148\/radiology.140.1.6454164","article-title":"The hypereosinophilic syndrome","volume":"140","author":"Epstein","year":"1981","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2026.01.027_bib85","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1148\/radiology.216.3.r00se01773","article-title":"Eosinophilic lung diseases: diagnostic accuracy of thin-section CT in 111 patients","volume":"216","author":"Johkoh","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.jaip.2026.01.027_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.rmed.2010.09.011","article-title":"Lung involvement in hypereosinophilic syndromes","volume":"105","author":"Dulohery","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108982","article-title":"What we have learned about lymphocytic variant hypereosinophilic syndrome: a systematic literature review","volume":"237","author":"Shi","year":"2022","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaip.2026.01.027_bib88","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.jaip.2021.01.030","article-title":"CD3-CD4+ lymphocytic variant hypereosinophilic syndrome: diagnostic tools revisited","volume":"9","author":"Carpentier","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.01.027_bib89","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/bjh.17615","article-title":"Treatment of lymphocyte-variant hypereosinophilic syndrome (L-HES): what to consider after confirming the elusive diagnosis","volume":"195","author":"Williams","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaip.2026.01.027_bib90","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2026.01.027_bib91","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.01.027_bib92","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajh.26966","article-title":"The international consensus classification of eosinophilic disorders and systemic mastocytosis","volume":"98","author":"Wang","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2026.01.027_bib93","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ejh.14396","article-title":"Clinical management of persistent hypereosinophilia","volume":"114","author":"Helbig","year":"2025","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jaip.2026.01.027_bib94","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ajh.27287","article-title":"World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Shomali","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jaip.2026.01.027_bib95","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1182\/blood.2023022417","article-title":"How I diagnose and treat myeloid\/lymphoid neoplasms with tyrosine kinase gene fusions","volume":"145","author":"Reiter","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.01.027_bib96","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41375-023-01859-3","article-title":"Comprehensive response criteria for myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group","volume":"37","author":"Shomali","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2026.01.027_bib97","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1182\/blood.2024028000","article-title":"Role of allo-HCT in \u201cnonclassical\u201d MPNs and MDS\/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT","volume":"145","author":"Polverelli","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.01.027_bib98","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/bloodadvances.2021004237","article-title":"A novel activating JAK1 mutation in chronic eosinophilic leukemia","volume":"5","author":"Shomali","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2026.01.027_bib99","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41375-018-0342-3","article-title":"Recurrent activating STAT5B N642H mutation in myeloid neoplasms with eosinophilia","volume":"33","author":"Cross","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2026.01.027_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-234638","article-title":"Acute lupus pneumonitis as the initial presentation of systemic lupus erythematosus","volume":"13","author":"Cantero","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib101","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3390\/ph14030276","article-title":"Respiratory manifestations in systemic lupus erythematosus","volume":"14","author":"Di Bartolomeo","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jaip.2026.01.027_bib102","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/09612033221088177","article-title":"Organizing pneumonia as a possible pulmonary manifestation of systemic lupus erythematosus: three cases and a review of literature","volume":"31","author":"Ito","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.jaip.2026.01.027_bib103","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009688","article-title":"Drug-induced eosinophilic pneumonia: a review of 196 case reports","volume":"97","author":"Bartal","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.jaip.2026.01.027_bib104","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1111\/1346-8138.14905","article-title":"Drug-induced acute eosinophilic pneumonia due to hydroxychloroquine in a chilblain lupus patient","volume":"46","author":"Ishiguro","year":"2019","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-251136","article-title":"Diagnosis of systemic lupus erythematosus with early manifestation of an eosinophilic pleural effusion","volume":"15","author":"Cho","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib106","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.reuma.2014.02.002","article-title":"Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis","volume":"10","author":"Mart\u00ednez-Mart\u00ednez","year":"2014","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.jaip.2026.01.027_bib107","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-0039-1685537","article-title":"Pulmonary complications of systemic lupus erythematosus","volume":"40","author":"Hannah","year":"2019","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib108","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2214\/AJR.16.17315","article-title":"A review of clinical and imaging findings in eosinophilic lung diseases","volume":"208","author":"Bernheim","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jaip.2026.01.027_bib109","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/annrheumdis-2021-221794","article-title":"2022 American College of Rheumatology\/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis","volume":"81","author":"Grayson","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib111","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211032437","article-title":"Interstitial lung disease pathology in systemic sclerosis","volume":"13","author":"Konopka","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib112","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1309\/AJCPJ6W9XOFEXIYS","volume":"130","author":"Rossi","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jaip.2026.01.027_bib113","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.3390\/ph15121584","article-title":"The role of bronchoalveolar lavage in systemic sclerosis interstitial lung disease: a systematic literature review","volume":"15","author":"Orlandi","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jaip.2026.01.027_bib114","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.rmed.2013.03.015","article-title":"Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis","volume":"107","author":"Hesselstrand","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib115","first-page":"111","article-title":"BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis","volume":"21","author":"Meloni","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib116","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/thx.35.12.957","article-title":"Pulmonary eosinophilia caused by penicillamine","volume":"35","author":"Davies","year":"1980","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.01.027_bib117","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.81.3.376","article-title":"D-Penicillamine-induced severe pneumonitis","volume":"81","author":"Camus","year":"1982","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.01.027_bib118","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.21037\/jtd-20-651","article-title":"Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases","volume":"12","author":"Davidson","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib119","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib120","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib121","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.55563\/clinexprheumatol\/h9tc57","article-title":"Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk\/prognostic factors, and treatment landscape","volume":"39","author":"Fazeli","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/09059180.00008014","article-title":"Rheumatoid arthritis-associated lung disease","volume":"24","author":"Shaw","year":"2015","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2026.01.027_bib123","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2169\/internalmedicine.47.0644","article-title":"Eosinophilic pneumonia (EP) associated with rheumatoid arthritis in which drug-induced eosinophilic pneumonia could be ruled out","volume":"47","author":"Tambo","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib124","article-title":"Eosinophilic pneumonia associated with rheumatoid arthritis: description of a case report and review of the literature","volume":"2","author":"Priora","year":"2015","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib125","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fmed.2019.00238","article-title":"Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment","volume":"6","author":"Fragoulis","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2026.01.027_bib126","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.027_bib127","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3899\/jrheum.150674","article-title":"Leflunomide use and risk of lung disease in rheumatoid arthritis: a systematic literature review and metaanalysis of randomized controlled trials","volume":"43","author":"Conway","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib128","doi-asserted-by":"crossref","first-page":"317","DOI":"10.46497\/ArchRheumatol.2024.10199","article-title":"Rituximab for rheumatoid arthritis-related interstitial lung disease: a systematic review and meta-analysis","volume":"39","author":"Boppana","year":"2024","journal-title":"Arch Rheumatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib129","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4065\/75.6.586","article-title":"Peripheral blood eosinophilia in association with sarcoidosis","volume":"75","author":"Renston","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2026.01.027_bib130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-2007-991521","article-title":"Bronchoalveolar lavage in sarcoidosis","volume":"28","author":"Drent","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/03009730802579729","article-title":"BAL fluid cells in newly diagnosed pulmonary sarcoidosis with different clinical activity","volume":"114","author":"Danila","year":"2009","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.jaip.2026.01.027_bib132","first-page":"990","article-title":"Eosinophilic pneumonia with marked peripheral eosinophilia during the course of sarcoidosis","volume":"17","author":"Okauchi","year":"2022","journal-title":"Maedica (Bucur)"},{"key":"10.1016\/j.jaip.2026.01.027_bib133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2466-5-8","article-title":"Th1\/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis","volume":"5","author":"Tsiligianni","year":"2005","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib134","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2796.2003.01074.x","article-title":"The cytokine network in sarcoidosis and its clinical relevance","volume":"253","author":"Ziegenhagen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.jaip.2026.01.027_bib135","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1164\/ajrccm\/142.3.642","article-title":"Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils","volume":"142","author":"Allen","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib136","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.03.00010403","article-title":"Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis","volume":"21","author":"Ziegenhagen","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.027_bib137","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11882-022-01039-w","article-title":"The role of T helper type 2 (Th2) cytokines in the pathogenesis of eosinophilic granulomatosis with polyangiitis (eGPA): an illustrative case and discussion","volume":"22","author":"Milne","year":"2022","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2026.01.027_bib138","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.3390\/ijms26136065","article-title":"Immunopathology of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis","volume":"26","author":"Lisowska","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2026.01.027_bib139","article-title":"Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS\/ATS statement","volume":"66","author":"Ryerson","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.01.027_bib140","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-3-030-68748-9_5","article-title":"Interstitial lung disease associated with connective tissue diseases","volume":"1304","author":"Peredo","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jaip.2026.01.027_bib141","doi-asserted-by":"crossref","DOI":"10.1177\/17534666221117002","article-title":"Immunomodulatory treatment of interstitial lung disease","volume":"16","author":"van den Bosch","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jaip.2026.01.027_bib142","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1016\/S2665-9913(23)00243-6","article-title":"Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study","volume":"5","author":"Bettiol","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib144","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/art.41943","article-title":"Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study","volume":"74","author":"Bettiol","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaip.2026.01.027_bib145","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1136\/ard-2022-222776","article-title":"Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study","volume":"81","author":"Bettiol","year":"2022","journal-title":"Ann Rheum Dis"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826000784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:51:31Z","timestamp":1781265091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826000784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":144,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213219826000784"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.027","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Diagnosis of Eosinophilic Lung Diseases","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}